Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 15:9:823797.
doi: 10.3389/fcvm.2022.823797. eCollection 2022.

WiSE CRT Is Beneficial for Heart Failure Patients as a Rescue Therapy: Evidence From a Meta-Analysis

Affiliations

WiSE CRT Is Beneficial for Heart Failure Patients as a Rescue Therapy: Evidence From a Meta-Analysis

Jiehui Cang et al. Front Cardiovasc Med. .

Abstract

Background: Leadless endocardial left ventricular (LV) pacing resynchronization therapy is a novel solution for patients with heart failure (HF) in whom conventional cardiac resynchronization therapy (CRT) failed.

Methods: PubMed and the Cochrane Library were searched for relevant cohort studies. Clinical outcomes of interest such as ejection fraction (EF), QRS duration (QRSd), and left ventricular end-systolic volume (LVESV) were extracted and analyzed.

Results: Five studies involving 175 HF patients for WiSE CRT were included, and patients were followed-up for 6 months. The implanted success rate ranged from 76.5 to 100%. WiSE CRT resulted in significantly narrower QRSd [mean difference (MD): -38.21 ms, 95% confidence interval (CI): -44.36 to -32.07, p < 0.001], improved left ventricular ejection fraction (MD: 6.07%, 95% CI: 4.43 to 7.71, I2 = 0%, p < 0.001), reduced left ventricular end-systolic volume (MD: -23.47 ml, 95% CI: -37.18 to -9.13, p < 0.001), and reduced left ventricular end-diastolic volume (MD: -24.02 ml, 95% CI: -37.01 to -11.03, p = 0.02).

Conclusion: Evidence from current studies suggests that leadless endocardial LV pacing resynchronization is effective for HF patients who failed conventional CRT or needed a device upgrade, and it may be an interesting rescue therapy.

Keywords: CRT; WiSE system; endocardial pacing; heart failure; leadless cardiac pacing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of database search and study identification.
Figure 2
Figure 2
Forest plots for the meta-analysis. (A) QRSd, (B) LVEDV, (C) LVESV, and (D) LVEF.
Figure 3
Figure 3
Funnel plots for the meta-analysis. (A) QRSd, (B) LVEDV, (C) LVESV, and (D) LVEF.

Similar articles

Cited by

References

    1. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, et al. . Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. (2007) 297:2502–14. 10.1001/jama.297.22.2502 - DOI - PubMed
    1. Sohaib SM, Chen Z, Whinnett ZI, Bouri S, Dickstein K, Linde C, et al. . Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy. Eur J Heart Fail. (2013) 15:1419–28. 10.1093/eurjhf/hft139 - DOI - PubMed
    1. Bleeker GB, Schalij MJ, Bax JJ. Importance of left ventricular lead position in cardiac resynchronization therapy. Eur Heart J. (2007) 28:1182–3. 10.1093/eurheartj/ehm085 - DOI - PubMed
    1. Seifert M, Schau T, Moeller V, Neuss M, Meyhoefer J, Butter C. Influence of pacing configurations, body mass index, and position of coronary sinus lead on frequency of phrenic nerve stimulation and pacing thresholds under cardiac resynchronization therapy. Europace. (2010) 12:961–7. 10.1093/europace/euq119 - DOI - PubMed
    1. Reddy VY, Miller MA, Neuzil P, Søgaard P, Butter C, Seifert M, et al. . Cardiac resynchronization therapy with wireless left ventricular endocardial pacing: the SELECT-LV Study. J Am Coll Cardiol. (2017) 69:2119–29. 10.1016/j.jacc.2017.02.059 - DOI - PubMed

Publication types